Where the Nation turns for Independent, Expert Advice
Text Size
The BoardThe Division The Academies
Study Task

The National Academy of Sciences will provide an assessment of cancer risks in populations living near U.S. Nuclear Regulatory Commission-licensed nuclear facilities. This assessment will be carried out in two consecutive phases:

A Phase 1 scoping study will identify scientifically sound approaches for carrying out the cancer epidemiology study that has been requested by the U.S. Nuclear Regulatory Commission. It will address the following tasks:

1. Methodological approaches for assessing off-site radiation dose, including consideration of:

  • Pathways, receptors, and source terms
  • Availability, completeness, and quality of information on gaseous and liquid radioactive releases and direct radiation exposure from nuclear facilities
  • Approaches for overcoming potential methodological limitations arising from the variability in radioactive releases over time and other confounding factors
  • Approaches for characterizing and communicating uncertainties


2. Methodological approaches for assessing cancer epidemiology, including consideration of:

  • Characteristics of the study populations (e.g., socioeconomic factors, all age groups, children only, and nuclear facility workers)
  • Geographic areas to use in the study (e.g., county, zip codes, census tracts, or annular rings around the facility at some nominal distances)
  • Cancer types and health outcomes of morbidity and mortality data
  • Availability, completeness, and quality of cancer incidence and mortality data
  • Different epidemiological study designs and statistical assessment methods (e.g., ecologic or case-control study designs)
  • Approaches for overcoming potential methodological limitations arising from low statistical power, random clustering, changes in population characteristics over time, and other confounding factors
  • Approaches for characterizing and communicating uncertainties


The results of this Phase 1 scoping study will be used to inform the design of the cancer risk assessment, which will be carried out in Phase 2.